SMO and neoplasm: The mutation incidence in tumor samples was as follows: NF2 R57* (15/27), PIK3CA E545K (13/27), BRAF Hotspot mutations (10/27), SMO L412F (9/27), SMO W535L (7/27), with varying mutant allele frequencies represented by the dot sizes.